COMETRIQ for Lung neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where COMETRIQ was used for Lung neoplasm malignant.
Most Reported Side Effects for COMETRIQ
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 75 | 49.7% | 19 | 11 |
| Fatigue | 48 | 31.8% | 8 | 9 |
| Diarrhoea | 39 | 25.8% | 10 | 7 |
| Stomatitis | 29 | 19.2% | 2 | 6 |
| Nausea | 23 | 15.2% | 2 | 6 |
| Death | 20 | 13.3% | 20 | 7 |
| Decreased appetite | 18 | 11.9% | 6 | 4 |
| Dry mouth | 16 | 10.6% | 0 | 1 |
| Malignant neoplasm progression | 16 | 10.6% | 13 | 3 |
| Pain in extremity | 16 | 10.6% | 1 | 1 |
| Dysgeusia | 15 | 9.9% | 0 | 2 |
| Dysphonia | 15 | 9.9% | 3 | 2 |
| Asthenia | 14 | 9.3% | 3 | 7 |
| Dyspnoea | 13 | 8.6% | 4 | 3 |
| Hair colour changes | 10 | 6.6% | 0 | 1 |
Other Indications for COMETRIQ
Other Drugs Used for Lung neoplasm malignant
ERLOTINIB (9,207)
OSIMERTINIB (4,754)
NIVOLUMAB (4,197)
PEMBROLIZUMAB (3,575)
CARBOPLATIN (3,487)
ALECTINIB (2,932)
PEMETREXED (2,422)
CRIZOTINIB (1,949)
BEVACIZUMAB (1,810)
PACLITAXEL (1,747)